This site is intended for UK healthcare professionals
Medscape UK Univadis Logo
Medscape UK Univadis Logo

Naphazoline hydrochloride ocular


Eye drops containing naphazoline hydrochloride (preservative containing)

Drugs List

  • naphazoline 0.012% eye drops
  • Therapeutic Indications


    Eye redness due to minor irritations : short-term symptomatic relief



    Instil 1 or 2 drops into each eye two to three times a day.


    Children 12 years and over
    Instil 1 or 2 drops into each eye two to three times a day.


    Children under 12 years
    Wearing of contact lenses
    Acute iritis
    Corneal damage
    Severe ocular disorder

    Precautions and Warnings

    Cardiovascular disorder
    Diabetes mellitus

    Do not use prior to peripheral iridectomy if predisposed to glaucoma
    Advise patient blurred vision may affect ability to drive/operate machinery
    Contains benzalkonium chloride
    To reduce systemic absorption compress lacrimal sac during administration
    Discontinue prior to anaesthetics which sensitise to sympathomimetics
    Discontinue if irritation persists/worsens or continued redness occurs
    Discontinue if patient develops decreased visual acuity +/or ocular pain
    Advise patient to avoid touching the eye/other surfaces with container tip
    Remove contact lenses before use and re-insert 15 minutes after use

    Pregnancy and Lactation


    Naphazoline hydrochloride eye drops are considered safe for use in pregnancy.

    The use of all medication in pregnancy should be avoided whenever possible; particularly in the first trimester. Non-drug treatments should also be considered. When essential, a medication with the best safety record over time should be chosen, employing the lowest effective dose for the shortest possible time. Polypharmacy should be avoided. Teratogens taken in the pre-embryonic period, often quoted as lasting until 14 to 17 days post-conception, are believed to have an all-or-nothing effect. Where drugs have a short half-life, and when the date of conception is certain, this may allow women to be reassured where drug exposure has occurred within this time frame. Further advice may be available from the UK National Teratology Information Service (NTIS) and through ToxBase, available via password on the internet ( ) or if this is unavailable at the backup site ( ).


    Naphazoline hydrochloride eye drops are considered safe for use in breastfeeding.

    Neonates, infants born prematurely, those with low birth weight, those with an unstable gastrointestinal function or who have serious illnesses may require special consideration. For any infant, if a drug is prescribed to the nursing mother, it should be at the lowest practical dose and for the shortest time. When drug administration is unavoidable and breastfeeding is to continue, minimisation of exposure of the infant to the drug may sometimes be achieved by timing the maternal doses to just after a feeding episode. Infants exposed to drugs via breast milk should be monitored for unusual signs or symptoms. Interactions between the drug received by the infant from the mother's milk and medication prescribed for the infant should also be considered, for example, when the drug given to the infant may prevent metabolism of the drug received via breast milk.
    Specialist advice is available from the UK Drugs in Lactation Advisory Service at

    Side Effects

    Blurred vision (transient)
    Dilatation of pupils


    It is strongly recommended that the UK National Poisons Information Service be consulted on cases of suspected or actual overdose where there is doubt over the degree of risk or about appropriate management.

    The following number will direct the caller to the relevant local centre (0844) 892 0111

    Information may be obtained if you have access to ToxBase the primary clinical toxicology database of the National Poisons Information Service. This is available via password on the internet ( ) or if this is unavailable at the backup site ( ).

    Further Information

    Last Full Review Date: May 2017

    Reference Sources

    Summary of product characteristics: Murine irritation & redness relief 0.012% eye drops. Prestige brands (UK) Limited. Revised December 2016.

    Access the full UK drug database with a FREE Medscape UK Account
    It takes just a few minutes, and you’ll get unlimited access to information on over 11,000 UK drugs.
    Register for Free

    Already a member? Log in

    Medscape UK | Univadis prescription drug monographs & interactions are based on FDB Multilex Content

    FDB Logo

    FDB Disclaimer : FDB Multilex is intended for the use of healthcare professionals and is provided on the basis that the healthcare professionals will retain FULL and SOLE responsibility for deciding what treatment to prescribe or dispense for any particular patient or circumstance.